全文获取类型
收费全文 | 1930篇 |
免费 | 154篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 60篇 |
妇产科学 | 8篇 |
基础医学 | 122篇 |
口腔科学 | 11篇 |
临床医学 | 131篇 |
内科学 | 263篇 |
神经病学 | 60篇 |
特种医学 | 58篇 |
外科学 | 96篇 |
综合类 | 123篇 |
预防医学 | 1041篇 |
眼科学 | 2篇 |
药学 | 87篇 |
中国医学 | 6篇 |
肿瘤学 | 28篇 |
出版年
2023年 | 22篇 |
2022年 | 41篇 |
2021年 | 80篇 |
2020年 | 84篇 |
2019年 | 85篇 |
2018年 | 87篇 |
2017年 | 86篇 |
2016年 | 69篇 |
2015年 | 68篇 |
2014年 | 120篇 |
2013年 | 129篇 |
2012年 | 116篇 |
2011年 | 124篇 |
2010年 | 105篇 |
2009年 | 91篇 |
2008年 | 83篇 |
2007年 | 90篇 |
2006年 | 79篇 |
2005年 | 68篇 |
2004年 | 67篇 |
2003年 | 53篇 |
2002年 | 69篇 |
2001年 | 35篇 |
2000年 | 33篇 |
1999年 | 33篇 |
1998年 | 19篇 |
1997年 | 13篇 |
1996年 | 20篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1993年 | 13篇 |
1992年 | 11篇 |
1991年 | 9篇 |
1990年 | 6篇 |
1989年 | 16篇 |
1988年 | 3篇 |
1987年 | 13篇 |
1986年 | 9篇 |
1985年 | 6篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1977年 | 2篇 |
1973年 | 1篇 |
排序方式: 共有2099条查询结果,搜索用时 15 毫秒
1.
Andreu Nolasco Eva M. Vicent-Castelló Pamela Pereyra-Zamora Pablo Caballero-Pérez Joaquín Moncho 《Gaceta sanitaria / S.E.S.P.A.S》2019,33(6):504-510
ObjectiveTo describe the evolution of mortality risks for complications due to medical care or surgery between the periods prior to (2002-2007) and after (2008-2013) the beginning of the economic crisis for Spain and by autonomous region, and to analyse the relationship between the changes in the risks of death and the socioeconomic impact of the crisis and the variation in health spending.MethodEcological study based on age-standardized mortality rates, synthetic index of vulnerability as a socioeconomic indicator and variation in health expenditure as an indicator of health expenditure. The relative risk of death between periods was estimated with Poisson regression models.ResultsThe number of deaths increased for Spain in the period studied. Although the relationship between the increase in public investment in health and the decrease in mortality due to this cause has not been clearly demonstrated, it was possible to determine that the autonomous regions with the lowest increase in health expenditure had rates higher than the rest throughout the period, and that the most vulnerable to the crisis and with the lowest increase in spending presented the greatest increase in the risk of death between the periods.ConclusionsGiven the increase in these deaths, due to avoidable failures of the system, it is necessary to continue investigating this cause of mortality. 相似文献
2.
目的:通过测算粤港澳大湾区卫生支出效率,评价其卫生支出综合绩效,并从经济、人口、政策、教育4个维度考察其对政府卫生支出效率的影响。方法:基于2010-2017年大湾区各地区面板数据,采用DEA-Tobit两步法对大湾区卫生支出效率及其影响因素进行实证检验。结果:2010-2017年间大湾区大部分地区卫生支出效率未达到DEA有效,人均GDP、城镇化水平与人口密度是卫生支出效率的重要影响因素。结论:粤港澳大湾区应进一步优化支出结构,培养创新人才,加强政府监督,促进大湾区医卫人员与患者间的沟通,真正打造粤港澳大湾区卫生共同体。 相似文献
3.
Seo‐Hyuk Chang No‐Joon Song Jin Hee Choi Ui Jeong Yun Kye Won Park 《Obesity reviews》2019,20(2):241-251
The growing focus on brown adipocytes has spurred an interest in their potential benefits for metabolic diseases. Brown and beige (or brite) adipocytes express high levels of uncoupling protein 1 (Ucp1) to dissipate heat instead of generating ATP. Ucp1 induction by stimuli including cold, exercise, and diet increases nonshivering thermogenesis, leading to increased energy expenditure and prevention of obesity. Recently, studies in adipocytes have indicated the existence of functional Ucp1‐independent thermogenic regulators. Furthermore, substrate cycling involving creatine metabolites, cold‐induced N‐acyl amino acids, and oxidized lipids in white adipocytes can increase energy expenditure in the absence of Ucp1. These studies emphasize the need for a better understanding of the mechanisms governing energy expenditure in adipocytes and their potential applications in the prevention of human obesity and metabolic diseases. 相似文献
4.
目的 综合分析新疆心脑血管疾病总治疗费用现状,为医疗资源的合理配置提供理论依据。方法 通过多阶段分层随机抽样,收集2017年新疆心脑血管疾病患者样本信息。在SHA 2011框架下,采用自上而下的分摊方法,核算心脑血管疾病的治疗费用。建立线性回归模型,用以分析住院费用的影响因素。结果 心脑血管疾病总治疗费用达105.74亿元;占比67.22%的治疗费用发生在综合医院;排名前三位的疾病分别为冠心病、高血压和脑梗塞,占比达74.20%;65岁及以上老年人群花费占比为43.51%;县(区)级机构(t = - 218.362,P<0.001)、市级机构(t = - 103.65,P<0.001)、住院天数(t = 233.297,P<0.001)、65岁以上人群(t = 58.422,P<0.001)、手术情况(t = 101.514,P<0.001)均是影响住院费用的主要因素。结论 新疆心脑血管疾病消耗大量医疗资源;防控工作重点关注老年人群;治疗费用机构流向有待优化,应强化基层医疗机构在防治慢病工作中的主导作用;缩短住院时间是有效控制治疗费用的直接途径。 相似文献
5.
Objective
To empirically assess the effect of adopting Affordable Care Act's Community First Choice (CFC) option on overall state home and community-based services (HCBS) expenditures as well as distribution of HCBS expenditures across different HCBS mechanisms. We also explore the heterogeneous effect of CFC across adopting states.Data Source
We used data from the Medicaid Long Term Services and Support (LTSS) expenditure reports prepared by Truven Analytics and Mathematica for the Centers for Medicare & Medicaid Services from 2008–2018 for all 48 states and the District of Columbia.Study Design
An event-study difference-in-differences model was used to estimate the effect of CFC on HCBS expenditures using Medicaid LTSS expenditure reports from 2008–2018. We also employ the synthetic control method to unmask heterogeneity across CFC adopting states using data from 2008–2018.Data Collection/Extraction Methods
Not applicable.Principal Findings
Overall, CFC was not associated with a change in HCBS expenditures per capita or HCBS expenditures as a proportion of LTSS expenditures. However, there appears to be an increase in HCBS expenditures among states that were institutionally-oriented prior to CFC adoption. Additionally, CFC adoption was associated with an overall decrease in expenditures in alternative HCBS mechanisms (Personal Care Services State Plan Option and 1915(c) waivers), suggesting potential substitution across overlapping programs.Conclusion
Results indicate heterogeneity across states adopting CFC. More institutionally-oriented states appear to use CFC to expand HCBS. In contrast, more HCBS-oriented states appear to employ CFC to strategically restructure their overall portfolio and processes. 相似文献6.
目的 探讨应用长效α-干扰素联合利巴韦林治疗慢性丙型肝炎(CHC)患者疗效及静息能量消耗和营养状态的变化。方法 2017年4月~2019年4月我院收治的CHC患者48例,采用随机数字表法分为观察组24例和对照组24例,分别给予聚乙二醇干扰素α-2a(peg-IFNα-2a)和利巴韦林治疗或干扰素α-2a(IFNα-2a)联合利巴韦林治疗48 w。测量静息能量消耗(REE)和预测静息能量消耗(pREE),常规检测血清前白蛋白(PA)和白蛋白(ALB)水平,计算体质指数(BMI)。结果 在治疗48 w结束和随访6 m时,观察组完全应答率分别为62.5%和54.2%,显著高于对照组的37.5%和29.2%,差异有统计学意义(P<0.05);在观察组,用药前REE和pREE分别为(1504.6±481.5)kcal/d和(1432.3±229.3)kcal/d,在治疗结束时显著增加至(1822.1±546.7)kcal/d和(1241.8±208.6)kcal/d,对照组用药前REE和pREE分别为(1505.2±482.1)kcal/d和(1433.5±231.2)kcal/d,在治疗结束时,显著增加至(1824.4±547.6)kcal/d和(1243.1±208.8)kcal/d, 但两组之间REE和pREE变化无显著性差异(P>0.05);治疗前,观察组BMI及血清PA和ALB水平分别为(19.2±2.0)kg/m2、(161.5±45.2)mg/L和(38.4±4.2)g/L,在治疗结束时分别降为(17.1±1.5)kg/m2、(135.8±40.2)mg/L和(34.2±3.2)g/L,治疗前对照组BMI及血清PA和ALB水平分别为(19.3±2.1)kg/m2、(161.3±45.0)mg/L和(38.5±4.4)g/L,在治疗结束时分别降为(17.2±1.5)kg/m2、(136.3±40.2)mg/L和(34.2±3.1)g/L,但两组之间这些指标的变化无显著性差异(P>0.05)。结论 相对于IFNα-2a与利巴韦林联合,应用peg-IFNα-2a与利巴韦林联合治疗CHC患者能够获得更好的治疗效果,但无论何种治疗方案,均增加了能量消耗,降低了体质量和血清白蛋白水平,提示标准方案抗病毒治疗的不良反应还是值得重视的。 相似文献
7.
8.
9.
Amira Kassis Jean-Philippe Godin Sophie E. Moille Corine Nielsen-Moennoz Karine Groulx Sylviane Oguey-Araymon Fabienne Praplan Maurice Beaumont Julien Sauser Irina Monnard Anne-France Kapp Corinne Ammon-Zufferey Nathalie Frei Laurence Guignard Frederik Delodder Katherine Mace 《Clinical nutrition (Edinburgh, Scotland)》2019,38(4):1570-1580
10.